CoreValve Archives - Cardiovascular News

FDA approves Evolut PRO+

23rd September 2019

The US Food and Drug ...

FDA approves Sapien 3 Ultra, Sapien 3, and CoreValve for low-risk TAVI

16th August 2019

On 16 August, the US ...

TCT 2018: Longest-term data to date for CoreValve study show excellent valve durability out to five years

27th September 2018

New data presented at...

ACC 2018: Five-year data for CoreValve show strong haemodynamic performance

16th March 2018

New data from the Cor...

EuroPCR 2017: Study provides “first step” towards showing long-term durability of TAVI devices

28th June 2017

New data presented, b...

EuroPCR 2017: Excellent clinical outcomes for Medtronic’s CoreValve and Evolut systems in routine practice

16th May 2017

New positive data on ...

TAVI pacemaker issue is “an engineering problem that will be solved”

28th March 2017

The SURTAVI trial ind...

ACC 2017: FDA approves launch of CoreValve Evolut Pro

22nd March 2017

The FDA has approved ...

ACC 2017: CoreValve non-inferior to surgery in intermediate-risk patients

17th March 2017

Results from the SURT...

Japan’s Ministry of Health, Labor and Welfare approves reimbursement for Medtronic’s CoreValve Evolut R system

5th December 2016

Medtronic has been gr...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy